Get the app
NSE › Healthcare

Medicamen Biotech Limited (MEDICAMEQ)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹284.45-3.45%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
₹48 cr
Revenue YoY
+11.3%
Net profit
₹2 cr
Profit YoY
-1.6%
Net margin
4.4%

Key statistics

Market cap
₹400 cr
P/E
39.8
Forward P/E
0.0
P/B
1.59
Book value
₹234.32
EPS (TTM)
₹7.41
52-week high
₹446.36
52-week low
₹211.79
50-day MA
₹282.70
200-day MA
₹280.44
Beta
0.69

Shareholding

Promoters
40.46%

Largest named holders

HolderStake
Pharmadanica A/S9.88%
Veralogix Holdings(Pty) Ltd4.42%
Ginnerup Capital Aps2.62%
Ritesh Kantilal Oswal1.15%
Rajesh Madan1.14%

Recent filings & reports

DocumentDate
Annual report FY2026
MEDICAMEN BIOTECH LIMITED - FY 2025-26 SUMMARY HEADLINE NUMBERS • Market Capitalisation (as of 31 March 2026): ₹302.86 crores • Revenue from Operati		2026-09-03
Quarterly results · Q1 FY27
MEDICAMEN BIOTECH LIMITED - DOCUMENT SUMMARY HEADLINE NUMBERS • Q1 FY2026-27 Net Sales (Standalone): Rs 4,385.27 crore (down from Rs 5,468.08 crore 		2026-08-14
Quarterly results · Q4 FY26
MEDICAMEN BIOTECH LIMITED – COMPANY DOCUMENT SUMMARY HEADLINE NUMBERS • Financial Year Ended: March 31, 2026 • Dividend Recommended: Rs. 1.00 per Eq		2026-05-27
Quarterly results · Q3 FY26
MEDICAMEN BIOTECH LIMITED – FINANCIAL RESULTS SUMMARY Quarter and Nine Months Ended December 31, 2025 --- HEADLINE NUMBERS • Q3 FY2025-26 Standalon		2026-02-13
Quarterly results · Q2 FY26
MEDICAMEN BIOTECH LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Net Profit (H1 FY2025-26): Rs. 384.22 lakhs (standalone), Rs. 371.48 lakhs (consoli		2025-11-14
Annual report FY2025
MEDICAMEN BIOTECH LIMITED - ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Revenue from Operations (Standalone): ₹15,146.33 Lakhs in FY2024-25, do		2025-09-03
Quarterly results · Q1 FY26
MEDICAMEN BIOTECH LIMITED – BOARD MEETING OUTCOME SUMMARY Date: August 12, 2025 --- HEADLINE NUMBERS • Q1 FY2025-26 Financial Results: Un-audited s		2025-08-12
Quarterly results2025-02-11

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹1 / share
ex-date Sep 18, 2026 · record Sep 19, 2026		2026-09-18
Dividend₹1 / share
ex-date Sep 19, 2025		2025-09-19

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Medicamen Biotech Limited — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLenskart Solutions LtdLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LtdLupin Limited

Data updated 2026-10-19.